Feline Lymphoma

Feline lymphoma is the most common hematopoietic malignancy in cats, arising from the neoplastic proliferation of lymphocytes within various anatomical locations including the gastrointestinal tract, mediastinum, kidneys, nasal cavity, and skin [4]. It is broadly classified by anatomical site, histological grade (low, intermediate, or high), and immunophenotype (B-cell or T-cell origin), each carrying distinct clinical implications. The disease encompasses a wide biological spectrum — from indolent small cell gastrointestinal lymphoma with survival measured in years, to aggressive large cell or large granular lymphocyte (LGL) forms with survival measured in weeks to months [1][6]. Understanding the subtype is essential for treatment planning and prognostic counseling.

The exact cause of feline lymphoma is multifactorial, involving viral, environmental, and immunological factors:

Viral Associations: Historically, feline leukemia virus (FeLV) was strongly linked to lymphoma, particularly mediastinal and multicentric forms in young cats. The widespread use of FeLV vaccination has substantially reduced FeLV-associated cases; today, the majority of feline lymphomas are FeLV-negative, especially gastrointestinal forms. Feline immunodeficiency virus (FIV) may also contribute by causing chronic immune dysregulation that predisposes to lymphoid neoplasia.

Chronic Inflammation and Immune Dysregulation: Gastrointestinal lymphoma, particularly small cell (low-grade) T-cell lymphoma, is thought to arise from a continuum of chronic intestinal inflammation. Feline chronic enteropathy — including inflammatory bowel disease (IBD) — shares clinical, histologic, and even molecular features with alimentary small cell lymphoma, suggesting that prolonged mucosal immune stimulation may drive neoplastic transformation [3][7]. Differentiating IBD from low-grade alimentary lymphoma remains one of the most challenging diagnostic dilemmas in feline internal medicine [7].

Molecular and Immunophenotypic Mechanisms: Gastrointestinal lymphomas are predominantly T-cell in origin, with mucosal T-cell lymphoma representing the most common subtype and histologically resembling WHO enteropathy-associated T-cell lymphoma (EATCL) type II in humans [6]. Clonal T-cell receptor gene rearrangements can be demonstrated by PCR for antigen receptor rearrangements (PARR), supporting neoplastic origin [6]. B-cell lymphomas are less common in the GI tract but occur in other anatomical sites.

Large Granular Lymphocyte (LGL) Lymphoma: LGL lymphoma is a distinct, highly aggressive subtype arising from cytotoxic T-lymphocytes or natural killer cells. It is characterized by neoplastic cells bearing cytoplasmic granules and commonly involves the gastrointestinal tract, with concurrent involvement of the spleen, liver, and lymph nodes [1].

Cutaneous Lymphoma: Epitheliotropic cutaneous lymphoma (also termed cutaneous T-cell lymphoma) involves neoplastic T-lymphocytes with tropism for the epidermis and its adnexae, while nonepitheliotropic forms are found predominantly in the dermis and subcutis and may be of either B-cell or T-cell origin [2].

Environmental Factors: Secondhand tobacco smoke exposure has been suggested as a risk factor. Certain breeds may be predisposed, and older cats (typically >9 years) are at highest risk for alimentary forms.

Diagnosis of feline lymphoma requires integration of clinical findings, laboratory data, imaging, and tissue/cytological sampling:

Physical Examination: Abdominal palpation may reveal intestinal wall thickening, an abdominal mass, mesenteric lymphadenopathy, or bilateral renomegaly [4][6]. Thoracic auscultation may detect pleural effusion in mediastinal cases.

Laboratory Findings:

Key hematological and biochemical abnormalities to evaluate include:

• ·

  Complete Blood Count (CBC):

  • ·HCT (Hematocrit): Often low (non-regenerative anemia) — common in high-grade and renal lymphoma [4]
  • ·WBC: Variable — may be high (leukocytosis with circulating neoplastic lymphocytes in LGL lymphoma), low (lymphopenia), or within reference range [1]
  • ·PLT (Platelets): May be low (thrombocytopenia) in advanced or LGL disease [1]
  • ·Circulating large granular lymphocytes in peripheral blood smear: pathognomonic feature in some LGL cases [1]
• ·

  Serum Biochemistry:

  • ·ALB (Albumin): Low — hypoalbuminemia is common due to protein-losing enteropathy in alimentary forms [3][6]
  • ·GLOB (Globulins): High or low — may reflect chronic inflammation or immune dysregulation
  • ·BUN and CREA (Urea/Creatinine): High — azotemia frequently observed in renal lymphoma due to infiltrative destruction of renal parenchyma [4]
  • ·ALT: High — hepatic infiltration or secondary hepatopathy
  • ·TBIL (Total Bilirubin): May be high if hepatic involvement causes cholestasis
  • ·Calcium: Hypercalcemia may be present, particularly in mediastinal or multicentric forms
• ·

  Urinalysis: May reveal proteinuria, isosthenuria, or cylindruria in renal lymphoma [4]

• ·

  FeLV/FIV Serology: Should be performed in all cats as viral status influences prognosis and treatment decisions

Imaging:

• ·Thoracic radiography: Identifies pleural effusion, mediastinal mass, or pulmonary infiltrates. Standard component of staging workup [1]
• ·Abdominal ultrasonography: Essential for all suspected cases [1]. Findings include diffuse intestinal wall thickening with loss of normal layering (high-grade), focal masses, mesenteric lymph node enlargement, renomegaly with altered echogenicity [4], or a subtly thickened muscularis propria (low-grade)
• ·CT (Computed Tomography): Increasingly used for thorough staging and surgical planning

Cytology and Histopathology:

• ·Fine needle aspirate (FNA): Of accessible masses, lymph nodes, or organs — rapid, minimally invasive; can suggest lymphoma but may be insufficient for subtype classification
• ·Endoscopic or surgical biopsy: Gold standard for alimentary lymphoma; allows assessment of mucosal architecture, immunophenotyping, and clonality [6][7]. Full-thickness intestinal biopsy via laparotomy or laparoscopy is preferred for definitive diagnosis, particularly when differentiating IBD from small cell lymphoma [7]
• ·Immunohistochemistry (IHC): CD3 (T-cell marker) and CD20/CD79a (B-cell markers) to determine immunophenotype [6]
• ·PARR (PCR for Antigen Receptor Rearrangements): Molecular clonality testing to differentiate reactive (polyclonal) from neoplastic (monoclonal) lymphoid infiltrates; particularly valuable in equivocal cases [6][7]

Staging: The WHO staging system is applied. Standard minimum staging includes CBC, serum biochemistry, urinalysis, thoracic radiography, and abdominal ultrasound [1].

Treatment depends on anatomical location, histological grade, and patient performance status:

Low-Grade (Small Cell) Alimentary Lymphoma: The cornerstone treatment is the chlorambucil + prednisolone protocol (often called "chlorambucil-pred"), which is well-tolerated and achieves remission in the majority of cats [6][7]. This oral protocol is particularly advantageous for owner administration at home.

• ·Chlorambucil: Oral alkylating agent, given daily or pulse-dosing (e.g., every 2 weeks)
• ·Prednisolone: Oral corticosteroid, given daily; has anti-inflammatory and cytolytic properties

High-Grade (Large Cell) Lymphoma and LGL Lymphoma: More aggressive multi-agent chemotherapy protocols are required [1]:

• ·COP protocol: Cyclophosphamide, vincristine (Oncovin), and prednisolone — commonly used first-line
• ·CHOP protocol: Cyclophosphamide, doxorubicin (hydroxydaunorubicin), vincristine, and prednisolone — considered the most effective standard of care for high-grade disease, administered over approximately 19–25 weeks
• ·LGL lymphoma responds poorly to conventional chemotherapy, with low remission rates and short durations [1]

Rescue/Second-Line Chemotherapy: For relapsed or refractory lymphoma, rescue protocols have been evaluated. The LMA protocol (lomustine, methotrexate, and cytarabine) has been assessed for relapsed high-grade feline lymphoma, though the study population was small (n=13) and outcomes were limited, underscoring the need for better rescue options [8].

Mediastinal Lymphoma:

• ·Thoracocentesis for symptomatic pleural effusion (palliative/diagnostic)
• ·CHOP-based chemotherapy is the treatment of choice; many mediastinal cases are FeLV-associated and may respond well initially

Renal Lymphoma:

• ·Systemic chemotherapy (COP or CHOP) is used; renal involvement may limit drug dosing due to impaired clearance [4]
• ·Supportive care for chronic kidney disease (CKD) comorbidity: fluid therapy, phosphate restriction, anti-emetics

Cutaneous Lymphoma:

• ·Epitheliotropic cutaneous T-cell lymphoma: Lomustine is often used as a systemic agent; topical agents (e.g., corticosteroids) may provide palliation [2]
• ·Surgical excision for solitary lesions
• ·Radiation therapy for localized disease

Novel and Emerging Therapies: Recent advances include modifications to conventional protocols, immunotherapy approaches, and small molecule-targeted therapies currently in varying stages of regulatory approval or investigation [5]. These include kinase inhibitors and checkpoint immunotherapy, though most current evidence in cats remains preliminary [5].

Supportive Care:

• ·Anti-emetics (maropitant, ondansetron) for chemotherapy-induced nausea
• ·Appetite stimulants (mirtazapine, capromorelin) and nutritional support
• ·Cobalamin (vitamin B12) supplementation for cats with evidence of hypocobalaminemia due to ileal involvement [3]
• ·Gastrointestinal protectants as needed

Prognosis varies markedly by subtype and is among the most important information for owners and clinicians:

Low-Grade (Small Cell) Alimentary Lymphoma: This subtype carries the most favorable prognosis. In the landmark study by Moore et al., cats with mucosal T-cell lymphoma (the most common GI subtype) had a median survival of 29 months [6]. Many cats achieve durable clinical remission with chlorambucil and prednisolone, and some survive >3 years.

High-Grade (Large Cell) Alimentary/Multicentric Lymphoma: Prognosis is significantly worse. With CHOP-based chemotherapy, remission rates of approximately 50–70% may be achieved, but median survival times are typically in the range of 3–9 months, with relatively few long-term survivors. Relapse is common, and rescue options are limited [8].

Large Granular Lymphocyte (LGL) Lymphoma: This subtype carries a grave prognosis. In a retrospective study of 109 cats with LGL lymphoma, the disease was characterized by poor response to chemotherapy and very short survival times [1]. LGL lymphoma is considered one of the most aggressive feline lymphoma subtypes, with most cats surviving only weeks to a few months following diagnosis [1].

Renal Lymphoma: Renal lymphoma has historically been associated with a guarded prognosis. Outcomes depend on the degree of renal dysfunction at presentation and the response to chemotherapy [4]. Concurrent CKD can severely limit chemotherapy tolerance and reduce survival times.

Mediastinal Lymphoma: FeLV-positive cats with mediastinal lymphoma may achieve initial remission with chemotherapy, but long-term prognosis remains guarded. FeLV-negative cats may fare better.

Cutaneous Lymphoma: Epitheliotropic cutaneous lymphoma generally carries a poor long-term prognosis, with most cats surviving months rather than years despite treatment [2]. Nonepitheliotropic forms have variable outcomes depending on immunophenotype and extent of disease.

Rescue Treatment Outcomes: In a small study of 13 cats treated with the LMA rescue protocol (lomustine, methotrexate, cytarabine) for relapsed high-grade lymphoma, outcomes were poor, highlighting the limited efficacy of current rescue options and the urgent need for novel therapies [8][5].

There is no definitive prevention strategy for feline lymphoma, but the following measures may reduce risk:

Viral Disease Prevention:

• ·FeLV vaccination is the most impactful preventive measure historically associated with reducing FeLV-related lymphoma. All cats, especially those with outdoor access or exposure to other cats, should receive core FeLV vaccination per current guidelines
• ·FIV prevention through neutering, keeping cats indoors, and avoiding cat fights reduces FIV exposure and associated immune dysregulation

Environmental Risk Factor Reduction:

• ·Minimizing exposure to secondhand tobacco smoke is advisable, as an association with lymphoma risk has been suggested in some studies
• ·Reducing exposure to environmental carcinogens (pesticides, herbicides) where possible

Chronic Disease Management:

• ·Early and effective management of chronic gastrointestinal inflammatory conditions (IBD, chronic enteropathy) may theoretically reduce risk of malignant transformation, though a direct causal link has not been definitively proven [3][7]
• ·Regular veterinary health examinations, including abdominal palpation, are important for early detection in senior cats (>9 years)

Screening:

• ·Annual or biannual wellness examinations with CBC and biochemistry panels in senior cats allow detection of early cytopenias, hypoalbuminemia, or azotemia that may prompt further investigation
• ·Abdominal ultrasound in cats with unexplained weight loss or chronic GI signs enables early tissue sampling and diagnosis

There is currently no available vaccine against feline lymphoma itself. Research into immunotherapy and targeted prevention remains an active area of investigation [5].